In vitro investigations of the effect of probiotics and prebiotics on selected human intestinal pathogens
Author:
- 1 January 2002
- journal article
- Published by Oxford University Press (OUP) in FEMS Microbiology Ecology
- Vol. 39 (1) , 67-75
Abstract
This study investigated the effects of selected probiotic microorganisms, in combination with prebiotics, on certain human intestinal foodborne pathogens. Probiotics grown with different carbohydrate sources were observed to inhibit growth of Escherichia coli, Campylobacter jejuni and Salmonella enteritidis, with the extent of inhibition varying according to the carbohydrate source provided. Prebiotics identified as being preferentially utilised by the probiotics tested were oligofructose (FOS), inulin, xylo-oligosaccharide (XOS), and mixtures of inulin:FOS (80:20 w/w) and FOS:XOS (50:50 w/w). Two of the probiotics, Lactobacillus plantarum and Bifidobacterium bifidum were selected for further co-culture experiments. Each was combined with the selected prebiotics, and was observed to inhibit pathogen growth strongly. Results suggested that acetate and lactate were directly conferring antagonistic action, which was not necessarily related to a lowering of culture pH.Keywords
This publication has 10 references indexed in Scilit:
- Clinical Applications of Probiotic BacteriaInternational Dairy Journal, 1998
- The Effects of Fermentation Acids on Bacterial Growth1997
- Dietary Modulation of the Human Colonic Microbiota: Introducing the Concept of PrebioticsThe Journal of Nutrition, 1995
- Effect of Consumption of Lactic Cultures on Human Health1993
- Purification and Characterization of Glycerol Dehydratase from Lactobacillus reuteriApplied and Environmental Microbiology, 1990
- Effect ofLactobacillusGG Yoghurt in Prevention of Antibiotic Associated DiarrhoeaAnnals of Medicine, 1990
- Chemical characterization of an antimicrobial substance produced by Lactobacillus reuteriAntimicrobial Agents and Chemotherapy, 1989
- Production and isolation of reuterin, a growth inhibitor produced by Lactobacillus reuteriAntimicrobial Agents and Chemotherapy, 1988
- SUCCESSFUL TREATMENT OF RELAPSING CLOSTRIDIUM DIFFICILE COLITIS WITH LACTOBACILLUS GGThe Lancet, 1987
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978